#IN026
LightNews LightNews
educativ.bsky.social
Regional Banker/Teller - North By Northeast (IN026) Job educativ.net/jobs/job/40708...
July 4, 2025 at 9:59 PM
educativ.bsky.social
Regional Banker/Teller - North By Northeast (IN026) Job educativ.net/jobs/job/40708...
July 4, 2025 at 9:54 PM
educativ.bsky.social
Teller - North By Northeast (IN026) Job educativ.net/jobs/job/40652...
July 3, 2025 at 9:28 PM
educativ.bsky.social
Personal Banker - North By Northeast Branch (IN026) Job educativ.net/jobs/job/38417...
May 28, 2025 at 9:29 PM
andrewhao.com
The Noun Project is out to create a free database of symbols for a global visual language, wonderful http://is.gd/in026 (via @serenawu)
February 5, 2025 at 1:42 PM
newsen.bsky.social
Innorna Announces FDA Approval for IN026, Pioneering mRNA Therapies for Chronic Metabolic Disorders#USA#Cambridge#mRNA_Therapy#Innorna#IN026
Innorna Announces FDA Approval for IN026, Pioneering mRNA Therapies for Chronic Metabolic Disorders
Innorna has achieved a significant milestone with FDA approval for their mRNA-based therapy IN026, targeting refractory gout in patients. This innovation aims to transform treatment options for chronic metabolic diseases.
third-news.com
March 18, 2026 at 1:40 AM
newsen.bsky.social
Innorna's FDA Approval Signals New Hope for Chronic Metabolic Disease Treatments with mRNA Technology#USA#Cambridge#mRNA_Therapy#Innorna#IN026
Innorna's FDA Approval Signals New Hope for Chronic Metabolic Disease Treatments with mRNA Technology
Innorna announced FDA's approval of IND for IN026, paving the way for innovative mRNA therapies targeting chronic metabolic diseases, including refractory gout.
third-news.com
March 18, 2026 at 1:36 AM
newsen.bsky.social
Innorna Receives FDA Approval for IND of IN026, Pioneering mRNA Therapy for Gout#USA#Cambridge#mRNA_Therapy#Innorna#IN026
Innorna Receives FDA Approval for IND of IN026, Pioneering mRNA Therapy for Gout
Innorna has announced FDA clearance for IN026, an mRNA therapy targeting refractory gout, marking a significant advancement in chronic disease management.
third-news.com
March 18, 2026 at 1:07 AM
newsen.bsky.social
Innorna's IND Clearance for IN026 Marks a Milestone in mRNA Therapy Development#USA#Cambridge#mRNA_Therapy#Innorna#IN026
Innorna's IND Clearance for IN026 Marks a Milestone in mRNA Therapy Development
Innorna has announced FDA clearance for IN026, an mRNA-based treatment targeting refractory gout, set to revolutionize chronic disease therapy.
third-news.com
March 17, 2026 at 2:50 PM
newsen.bsky.social
Innorna Receives FDA IND Clearance for mRNA Drug IN026, Paving the Way for New Gout Treatment#USA#Massachusetts#mRNA_Therapy#Innorna#IN026
Innorna Receives FDA IND Clearance for mRNA Drug IN026, Paving the Way for New Gout Treatment
Innorna has received FDA IND clearance for IN026, an innovative mRNA-based therapy aimed at treating refractory gout, potentially revolutionizing treatment options for patients.
third-news.com
March 17, 2026 at 2:50 PM
l2plabs.bsky.social
Innorna annonce la désignation par la FDA de nouveau médicament de recherche pour IN026, faisant progresser les thérapies basées sur l'ARNm dans les maladies métaboliques chroniques
IN026 est une thérapie ARNm potentielle de premier ordre pour la goutte réfractaire, marquant l'émergence d'une nouvelle catégorie de médicaments ARNm rendus possibles par la plateforme propriétaire ARNm-LNP d'Innorna. HONG KONG RAS, Chine et SHENZHEN, Chine et CAMBRIDGE, Massachusetts,...
dlvr.it
March 18, 2026 at 1:33 AM
l2plabs.bsky.social
Innorna gibt die Genehmigung des IND-Antrags für IN026 durch die FDA bekannt und treibt damit die Entwicklung von mRNA-basierten Therapien für chronische Stoffwechselerkrankungen voran
IN026 ist eine potenzielle, in ihrer Klasse einzigartige mRNA-Therapie für refraktäre Gicht und markiert den Beginn einer neuen Kategorie von mRNA-Arzneimitteln, die durch die firmeneigene mRNA-LNP-Plattform von Innorna ermöglicht wird. SONDERVERWALTUNGSZONE HONGKONG, China und SHENZHEN,...
dlvr.it
March 18, 2026 at 1:29 AM